Li Y - Search Results

1

Impact of Recombinant VSV-HIV Prime, DNA-Boost Vaccine Candidates on Immunogenicity and Viremia on SHIV-Infected Rhesus Macaques.

Berger A, Pedersen J, Kowatsch MM, Scholte F, Lafrance MA, Azizi H, Li Y, Gomez A, Wade M, Fausther-Bovendo H, de La Vega MA, Jelinski J, Babuadze G, Nepveu-Traversy ME, Lamarre C, Racine T, Kang CY, Gaillet B, Garnier A, Gilbert R, Kamen A, Yao XJ, Fowke KR, Arts E, Kobinger G. Berger A, et al. Among authors: li y. Vaccines (Basel). 2024 Mar 29;12(4):369. doi: 10.3390/vaccines12040369. Vaccines (Basel). 2024. PMID: 38675751 Free PMC article.

2

Optimal Expression, Function, and Immunogenicity of an HIV-1 Vaccine Derived from the Approved Ebola Vaccine, rVSV-ZEBOV.

Azizi H, Knapp JP, Li Y, Berger A, Lafrance MA, Pedersen J, de la Vega MA, Racine T, Kang CY, Mann JFS, Dikeakos JD, Kobinger G, Arts EJ. Azizi H, et al. Among authors: li y. Vaccines (Basel). 2023 May 12;11(5):977. doi: 10.3390/vaccines11050977. Vaccines (Basel). 2023. PMID: 37243081 Free PMC article.

3

Rhesus macaques show increased resistance to repeated SHIV intrarectal exposure following a heterologous regimen of rVSV vector vaccine expressing HIV antigen.

Jelinski J, Kowatsch MM, Lafrance MA, Berger A, Pedersen J, Azizi H, Li Y, Scholte F, Gomez A, Hollett N, Le T, Wade M, Fausther-Bovendo H, de La Vega MA, Babuadze G, Xiii A, Lamarre C, Racine T, Kang CY, Yao XJ, Alter G, Arts E, Fowke KR, Kobinger GP. Jelinski J, et al. Among authors: li y. Emerg Microbes Infect. 2023 Dec;12(2):2251595. doi: 10.1080/22221751.2023.2251595. Emerg Microbes Infect. 2023. PMID: 37649434 Free PMC article.

4

Monovalent and trivalent VSV-based COVID-19 vaccines elicit neutralizing antibodies and CD8⁺ T cells against SARS-CoV-2 variants.

Parham KA, Kim GN, Richer CG, Ninkov M, Wu K, Saeedian N, Li Y, Rashu R, Barr SD, Arts EJ, Haeryfar SMM, Kang CY, Troyer RM. Parham KA, et al. Among authors: li y. iScience. 2023 Apr 21;26(4):106292. doi: 10.1016/j.isci.2023.106292. Epub 2023 Feb 28. iScience. 2023. PMID: 36915805 Free PMC article.

5

Enhancement of CD4 Binding, Host Cell Entry, and Sensitivity to CD4bs Antibody Inhibition Conferred by a Natural but Rare Polymorphism in the HIV-1 Envelope.

Ratcliff AN, Venner CM, Olabode AS, Knapp J, Pankrac J, Derecichei I, Gibson RM, Finzi A, Li Y, Mann JFS, Arts EJ. Ratcliff AN, et al. Among authors: li y. J Virol. 2022 Jul 27;96(14):e0185121. doi: 10.1128/jvi.01851-21. Epub 2022 Jul 5. J Virol. 2022. PMID: 35862673 Free PMC article.

6

A vesicular stomatitis virus-based prime-boost vaccination strategy induces potent and protective neutralizing antibodies against SARS-CoV-2.

Kim GN, Choi JA, Wu K, Saeedian N, Yang E, Park H, Woo SJ, Lim G, Kim SG, Eo SK, Jeong HW, Kim T, Chang JH, Seo SH, Kim NH, Choi E, Choo S, Lee S, Winterborn A, Li Y, Parham K, Donovan JM, Fenton B, Dikeakos JD, Dekaban GA, Haeryfar SMM, Troyer RM, Arts EJ, Barr SD, Song M, Kang CY. Kim GN, et al. Among authors: li y. PLoS Pathog. 2021 Dec 16;17(12):e1010092. doi: 10.1371/journal.ppat.1010092. eCollection 2021 Dec. PLoS Pathog. 2021. PMID: 34914812 Free PMC article.

7

High-level resistance to bictegravir and cabotegravir in subtype A- and D-infected HIV-1 patients failing raltegravir with multiple resistance mutations.

Ndashimye E, Li Y, Reyes PS, Avino M, Olabode AS, Kityo CM, Kyeyune F, Nankya I, Quiñones-Mateu ME, Barr SD, Arts EJ. Ndashimye E, et al. Among authors: li y. J Antimicrob Chemother. 2021 Oct 11;76(11):2965-2974. doi: 10.1093/jac/dkab276. J Antimicrob Chemother. 2021. PMID: 34453542 Free PMC article.

8

Replicative fitness and pathogenicity of primate lentiviruses in lymphoid tissue, primary human and chimpanzee cells: relation to possible jumps to humans.

Tebit DM, Nickel G, Gibson R, Rodriguez M, Hathaway NJ, Bain K, Reyes-Rodriguez AL, Ondoa P, Heeney JL, Li Y, Bongorno J, Canaday D, McDonald D, Bailey JA, Arts EJ. Tebit DM, et al. Among authors: li y. EBioMedicine. 2024 Feb;100:104965. doi: 10.1016/j.ebiom.2023.104965. Epub 2024 Jan 12. EBioMedicine. 2024. PMID: 38215691 Free PMC article.

9

Accumulation of integrase strand transfer inhibitor resistance mutations confers high-level resistance to dolutegravir in non-B subtype HIV-1 strains from patients failing raltegravir in Uganda.

Ndashimye E, Avino M, Olabode AS, Poon AFY, Gibson RM, Li Y, Meadows A, Tan C, Reyes PS, Kityo CM, Kyeyune F, Nankya I, Quiñones-Mateu ME, Arts EJ. Ndashimye E, et al. Among authors: li y. J Antimicrob Chemother. 2020 Dec 1;75(12):3525-3533. doi: 10.1093/jac/dkaa355. J Antimicrob Chemother. 2020. PMID: 32853364 Free PMC article.

10

Effective and targeted latency reversal in CD4⁺ T cells from individuals on long term combined antiretroviral therapy initiated during chronic HIV-1 infection.

Ngo MH, Pankrac J, Ho RCY, Ndashimye E, Pawa R, Ceccacci R, Biru T, Olabode AS, Klein K, Li Y, Kovacs C, Assad R, Jacobson JM, Canaday DH, Tomusange S, Jamiru S, Anok A, Kityamuweesi T, Buule P, Galiwango RM, Reynolds SJ, Quinn TC, Redd AD, Prodger JL, Mann JFS, Arts EJ. Ngo MH, et al. Among authors: li y. Emerg Microbes Infect. 2024 Dec;13(1):2327371. doi: 10.1080/22221751.2024.2327371. Epub 2024 Mar 26. Emerg Microbes Infect. 2024. PMID: 38444369 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

220,326 results

Search Page